Stenting versus aggressive medical therapy for intracranial arterial stenosis

New England Journal of Medicine

Volumn 365, Issue 11, 2011, Pages 993-1003

  Chimowitz, Marc I ^a   Lynn, Michael J ^b   Derdeyn, Colin P ^c   Turan, Tanya N ^a   Fiorella, David ^d   Lane, Bethany F ^b   Janis, L Scott ^e   Lutsep, Helmi L ^f   Barnwell, Stanley L ^f   Waters, Michael F ^g   Hoh, Brian L ^h   Hourihane, J Maurice ⁱ   Levy, Elad I ^j   Alexandrov, Andrei V ^k   Harrigan, Mark R ^l   Chiu, David ^m   Klucznik, Richard P ^m   Clark, Joni M ⁿ   McDougall, Cameron G ⁿ   Johnson, Mark D ^o   Pride Jr , G Lee ^o   Torbey, Michel T ^p   Zaidat, Osama O ^p   Rumboldt, Zoran ^a   Cloft, Harry J ^q   more..

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EMORY UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY AT BUFFALO   (United States)

^j UNIVERSITY AT BUFFALO   (United States)

^k The University of Alabama at Birmingham   (United States)

^l University of Alabama at Birmingham   (United States)

^m HOUSTON METHODIST HOSPITAL   (United States)

ⁿ BARROW NEUROLOGICAL INSTITUTE   (United States)

^o UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^p MEDICAL COLLEGE OF WISCONSIN   (United States)

^q MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUSE OF DEATH; CEREBRAL REVASCULARIZATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR HEMORRHAGE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; STENT; SUBDURAL HEMATOMA; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 80052834654     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1105335     Document Type: Article

References (39)

1. Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke 2006;1:158-9. (Pubitemid 44151508)
2. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008;39:2396-9.
3. Arenillas JF. Intracranial atherosclerosis: current concepts. Stroke 2011;42:Suppl:S20-S23.
4. Kim JS, Kang DW, Kwon SU. Intracranial atherosclerosis: incidence, diagnosis and treatment. J Clin Neurol 2005;1:1-7. (Pubitemid 40470499)
5. Sacco RL, Kargman D, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 1995;26:14-20.
6. Meseguer E, Lavallée PC, Mazighi M, et al. Yield of systematic transcranial Doppler in patients with transient ischemic attack. Ann Neurol 2010;68:9-17.
7. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-16.
8. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-63.
9. Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003;34:2361-6. (Pubitemid 37221942)
10. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008;70:1518-24. (Pubitemid 351589505)
11. Rasmussen PA, Perl J II, Barr JD, et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg 2000;92:771-8. (Pubitemid 30243924)
12. Levy EI, Hanel RA, Boulos AS, et al. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg 2003;99:653-60. (Pubitemid 37159041)
13. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007;61:236-42. (Pubitemid 47357287)
14. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388-92.
15. Kim JK, Ahn JY, Lee BH, et al. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004;75:847-51. (Pubitemid 38658506)
16. Suh DC, Kim JK, Choi JW, et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008;29:781-5. (Pubitemid 351596115)
17. de Rochemont RM, Turowski B, Buchkremer M, Sitzer M, Zanella FE, Berkefeld J. Recurrent symptomatic high-grade intracranial stenosis: safety and efficacy of undersized stents - initial experience. Radiology 2004;231:45-9. (Pubitemid 38375407)
18. Jiang WJ, Xu XT, Du B, et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 2007;68:420-6. (Pubitemid 46208744)
19. Yu SC, Leung TW, Lee KT, Hui JW, Wong LK. Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan: evaluation of clinical outcome, restenosis, and procedure outcome. AJNR Am J Neuroradiol 2011;32:753-8.
20. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531-7. (Pubitemid 46684170)
21. Chimowitz MI, Lynn MJ, Turan TN, et al. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis 2011;20:357-68.
22. Chaturvedi S, Turan TN, Lynn MJ, et al. Risk factor status and subsequent vascular events in patients with symptomatic intracranial stenosis. Neurology 2007;69:2063-8. (Pubitemid 350175708)
23. Gordon NF, Salmon RD, Franklin BA, et al. Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia. Am J Cardiol 2004;94:1558-61. (Pubitemid 40268463)
24. Lan KKG, Wittes J. The B-value: a tool for monitoring data. Biometrics 1988;44:579-85.
25. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881-7. (Pubitemid 46568447)
26. Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv 2007;70:1025-33.
27. Topakian R, Strasak AM, Sonnberger M, et al. Timing of stenting of symptomatic carotid stenosis is predictive of 30-day outcome. Eur J Neurol 2007;14:672-8. (Pubitemid 46850694)
28. Brott TG, Hobson RW II, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23. [Errata, N Engl J Med 2010;363:198, 498.]
29. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007;115:2969-75. (Pubitemid 46912100)
30. Wong KS, Chen C, Fu J, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010;9:489-97.
31. Derdeyn CP. Mechanisms of ischemic stroke secondary to large artery atherosclerotic disease. Neuroimaging Clin N Am 2007;17:303-11. (Pubitemid 47362738)
32. Wang X, Lam WW, Fan YH, Graham CA, Rainer TH, Wong KS. Topographic patterns of small subcortical infarcts associated with MCA stenosis: a diffusion-weighted MRI study. J Neuroimaging 2006;16:266-71. (Pubitemid 44939621)
33. Choi JW, Kim JK, Choi BS, et al. Angiographic pattern of symptomatic severe M1 stenosis: comparison with presenting symptoms, infarct patterns, perfusion status, and outcome after recanalization. Cerebrovasc Dis 2010;29:297-303.
34. Lee DK, Kim JS, Kwon SU, Yoo SH, Kang DW. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 2005;36:2583-8.
35. Famakin BM, Chimowitz MI, Lynn MJ, Stern BJ, George MG. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2009;40:1999-2003.
36. Turk AS, Levy EI, Albuquerque FC, et al. Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008;29:23-7.
37. Levy EI, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644-50. (Pubitemid 47442683)
38. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. [Erratum, JAMA 2003;290:197.]
39. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39. [Erratum, Circulation 2004;110:763.]